RUNX3 and cancer: While its function in cancer remains unclear, miR-5009-5p downregulation has been previously observed in sepsis, where it was implicated in the RUNX3–MAPK14–miR-19b-1-5p–miR-5009-5p regulatory axis, highlighting its potential as a therapeutic target [42].